Cancer Drugs In India May Get 20-70% Cheaper As NPPA Approves Price-Cutting Move | News18

A News18 report on a decision by India's National Pharmaceutical Pricing Authority (NPPA) to approve in principle a proposal to cap the trade margin on cancer medicines at 30 per cent of the maximum retail price (MRP). The report says this could lower prices of many cancer drugs by 20 to 70 per cent. The government estimates patients could save about Rs 2,500 crore a year. The trade margin is the difference between the factory price and the price paid by the patient, which sellers add along the supply chain.

• NPPA approved in principle a proposal to cap trade margins on cancer medicines
• Proposed cap: 30 per cent of the maximum retail price (MRP)
• Report says prices of many cancer drugs could fall by 20 to 70 per cent
• Government estimates patient savings of about Rs 2,500 crore a year

Many cancer medicines in India could become much cheaper, with prices falling by 20 to 70 per cent, after the government’s drug pricing watchdog, the National Pharmaceutical Pricing Authority (NPPA), approved a cap on how much sellers can add to the price between the factory and the patient. The authority has approved in principle a proposal to cap this difference, called the trade margin, at 30 per cent of the maximum retail price (MRP), the price printed on the pack. The government estimates that patients will save about Rs 2,500 crore a year. #CancerMedicines #CancerTreatment #NPPA #Healthcare #DrugPrices #IndiaNews #BreakingNews #CancerCare #CNNNews18 n18oc_breaking-news